doi: 10.4239/wjd.v7.i17.354 72 GallwitzB
Current research status Retatrutide is currently in Phase 3 clinical trials, with Eli Lilly conducting multiple large-scale studies
The clinical uses span gut healing, tissue repair, inflammation control, immune modulation, and indirect stimulation of growth hormone
L-carnitine supplementation had a significant effect on TG (WMD = 13.50 mg/dl), LDL (WMD = 12.66 mg/dl), HbA1c (WMD = -0.37%), FBG (WMD = 6.24 mg/dl), HOMA-IR (WMD = -0.72), CRP (WMD = 0.07 mg/dl), TNF- (WMD = 1.39 pg/ml), weight (WMD = 1.58 kg), BFP (WMD = 1.83), BMI (WMD = 0.28 kg/m2), and leptin (WMD = 2.21 ng/ml) in intervention, compared to the placebo group, in the pooled analysis
Reducing food intake may lessen nausea and vomiting
Comprehensive Program Design: Look beyond medication